Think.Health is a boutique venture capital firm based in Fürstenfeldbruck, Germany, investing in disruptive business models across digital healthcare, life sciences, pharmaceuticals, biotechnology, and medical technologies. The firm typically invests in early-stage ventures and growth opportunities with tickets ranging from €500k to €10m.
58% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $45.7M (across 5 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Dr. Florian Kainzinger
Managing Partner & Founder
Dr. Michael Ruoff
Partner
Nils Bottler
Venture Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Robeauté | Series B | — | Jan 2025 |
| Robeauté | Series A | $28M | Jan 2025 |
 SphingoTec | Series C | — | Aug 2024 |
 Navignostics | Seed | — | Nov 2022 |
 Inflammatix | Series D | $102M | Mar 2021 |
 Caspar | Series B | — | Jan 2021 |
| Inflammatix | Series C | $32M | Jan 2020 |
| SphingoTec | Series C | — | Jan 2018 |
 PreOmics | Series A | — | — |
| VVara | Series A | $9.5M | — |
| Caspar | Series A | — | — |
| Inflammatix | Series E | $57M | — |
Top Co-Investors
Northpond Ventures3 shared
Khosla Ventures3 shared
Plural Platform2 shared
Cherry Ventures2 shared
APEX Ventures2 shared
Index Ventures2 shared
Phoenix Court Group2 shared
Kindred Ventures2 shared
Wellington Management2 shared
Brandenburg Kapital2 shared
HBM Healthcare Investments2 shared
NRW.BANK2 shared
Atlantic Labs2 shared
Ananda Impact Ventures2 shared
D1 Capital Partners2 shared
OSF HealthCare2 shared
Stanford's StartX Fund1 shared
Scale Venture Partners1 shared
High-Tech Gründerfonds1 shared
HBM Partners1 shared
Last updated: 20 October 2026